All In MedTech

FDA Clearance Tracker · P150035

Aveir VR Leadless System

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Mar 31, 2022 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Mar 31, 2022

Approved

Time to decision

2,368 days

Received Oct 6, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P150035
Device name
Aveir VR Leadless System
Applicant location
Sylmar, CA
Received
Oct 6, 2015
Decided
Mar 31, 2022
Decision
Approved
Supplements
42 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Regulation
21 CFR 870.3610

Every decision under product code PNJ

FDA's approval statement

As written in FDA's record.

Approval for the Aveir Leadless Pacemaker, Aveir Delivery System Catheter, and Aveir Link Module.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code PNJ. The earliest in FDA's data is P150033, decided Apr 6, 2016.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.